Previous PostRejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York
Next PostRejuveron leads EUR 15.7 million Series B investment in Rejuvenate Biomed to accelerate clinical development of its sarcopenia treatment for healthy aging
